122 related articles for article (PubMed ID: 2126534)
1. Synthesis and characterization of nonionic paramagnetic metal complexes as potential magnetic resonance imaging contrast agents.
White DH; Rajagopalan R; Kuan KT; Lin Y; Wallace RA; Rogic MM; Bosworth ME; Robbins MS; Ralston WH; Adams MD
Invest Radiol; 1990 Sep; 25 Suppl 1():S56-7. PubMed ID: 2126534
[No Abstract] [Full Text] [Related]
2. The synthesis and screening of nonionic gadolinium (III) DTPA-bisamide complexes as magnetic resonance imaging contrast agents.
Periasamy M; White D; deLearie L; Moore D; Wallace R; Lin W; Dunn J; Hirth W; Cacheris W; Pilcher G
Invest Radiol; 1991 Nov; 26 Suppl 1():S217-20; discussion S232-5. PubMed ID: 1667003
[No Abstract] [Full Text] [Related]
3. Tolerance of extracellular contrast agents for magnetic resonance imaging.
Weinmann HJ; Press WR; Gries H
Invest Radiol; 1990 Sep; 25 Suppl 1():S49-50. PubMed ID: 2283256
[No Abstract] [Full Text] [Related]
4. Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat.
Cohan RH; Leder RA; Herzberg AJ; Hedlund LW; Wheeler CT; Beam CA; Nadel SN; Dunnick NR
Invest Radiol; 1991 Mar; 26(3):224-6. PubMed ID: 2055727
[TBL] [Abstract][Full Text] [Related]
5. The relationship between thermodynamics and the toxicity of gadolinium complexes.
Cacheris WP; Quay SC; Rocklage SM
Magn Reson Imaging; 1990; 8(4):467-81. PubMed ID: 2118207
[TBL] [Abstract][Full Text] [Related]
6. The synthesis and evaluation of macrocyclic gadolinium-DTPA-bis(amide) complexes as magnetic resonance imaging contrast agents.
Varadarajan JA; Crofts SP; Carvalho JF; Fellmann JD; Kim SH; Chang CA; Watson AD
Invest Radiol; 1994 Jun; 29 Suppl 2():S18-20. PubMed ID: 7928223
[TBL] [Abstract][Full Text] [Related]
7. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
Rubin DL; Muller HH; Young SW
Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
[TBL] [Abstract][Full Text] [Related]
8. Paramagnetic dextrans as magnetic resonance contrast agents.
Meyer D; Schaefer M; Bouillot A; Beauté S; Chambon C
Invest Radiol; 1991 Nov; 26 Suppl 1():S50-2; discussion S60-4. PubMed ID: 1725521
[No Abstract] [Full Text] [Related]
9. New magnetic resonance imaging contrast agents for infarct imaging based on phosphonate derivatives of Gd-DTPA.
Adzamli IK; Blau M; Pfeffer MA; Davis MA
Invest Radiol; 1991 Nov; 26 Suppl 1():S242-4; discussion S245-7. PubMed ID: 1808139
[No Abstract] [Full Text] [Related]
10. Comparative assessment of gadoxetate disodium, manganese dipyridoxal diphosphate, and superparamagnetic iron oxide for enhancement of the liver in dogs.
Khangure MS; Hua J
Acad Radiol; 1996 Aug; 3 Suppl 2():S458-60. PubMed ID: 8796629
[No Abstract] [Full Text] [Related]
11. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.
Yan GP; Hu B; Liu ML; Li LY
J Pharm Pharmacol; 2005 Mar; 57(3):351-7. PubMed ID: 15807991
[TBL] [Abstract][Full Text] [Related]
12. Fe-HBED Analogs: A Promising Class of Iron-Chelate Contrast Agents for Magnetic Resonance Imaging.
Bales BC; Grimmond B; Johnson BF; Luttrell MT; Meyer DE; Polyanskaya T; Rishel MJ; Roberts J
Contrast Media Mol Imaging; 2019; 2019():8356931. PubMed ID: 31969797
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide.
Chang CA
Invest Radiol; 1993 Mar; 28 Suppl 1():S21-7. PubMed ID: 8486500
[No Abstract] [Full Text] [Related]
14. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
[TBL] [Abstract][Full Text] [Related]
15. Advances in macrocyclic gadolinium complexes as magnetic resonance imaging contrast agents.
Meyer D; Schaefer M; Doucet D
Invest Radiol; 1990 Sep; 25 Suppl 1():S53-5. PubMed ID: 2132570
[No Abstract] [Full Text] [Related]
16. The functional effects of gadolinium-DTPA on the isolated perfused rat kidney.
Brown PW; Haylor JL; Morcos SK; el Nahas AM
Eur J Radiol; 1993 Feb; 16(2):85-9. PubMed ID: 8462585
[TBL] [Abstract][Full Text] [Related]
17. Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents.
Ferreira MF; Martins AF; Martins JA; Ferreira PM; Tóth E; Geraldes CF
Chem Commun (Camb); 2009 Nov; (42):6475-7. PubMed ID: 19841814
[TBL] [Abstract][Full Text] [Related]
18. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.
Fulton DA; O'Halloran M; Parker D; Senanayake K; Botta M; Aime S
Chem Commun (Camb); 2005 Jan; (4):474-6. PubMed ID: 15654374
[TBL] [Abstract][Full Text] [Related]
19. Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging.
Anelli PL; Lattuada L; Lorusso V; Lux G; Morisetti A; Morosini P; Serleti M; Uggeri F
J Med Chem; 2004 Jul; 47(14):3629-41. PubMed ID: 15214790
[TBL] [Abstract][Full Text] [Related]
20. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
